A Tick Antivirulence Protein Potentiates Antibiotics against Staphylococcus aureus

Area of Science:

• Microbiology
• Biochemistry
• Infectious Diseases

Background:

• Antibiotic resistance is a growing global health threat, necessitating novel therapeutic strategies.
• Methicillin-resistant Staphylococcus aureus (MRSA) is a particularly challenging pathogen due to its resistance mechanisms.
• Antifreeze glycoproteins (AFGPs) have shown potential for antimicrobial applications.

Purpose of the Study:

• To investigate the synergistic effects of a tick antifreeze glycoprotein (IAFGP) with antibiotics against Staphylococcus aureus.
• To evaluate the efficacy of IAFGP-antibiotic combinations in both in vitro and in vivo infection models.
• To explore the potential of IAFGP as an adjuvant therapy to overcome antibiotic resistance.

Main Methods:

• In vitro assessment of synergy between IAFGP (or its peptide P1) and various antibiotics against S. aureus.
• In vivo evaluation of synergistic combinations using vertebrate (transgenic mice) and invertebrate (flies) infection models.
• Analysis of antibiotic permeation into bacterial cells when combined with IAFGP.

Main Results:

• IAFGP demonstrated potent antibiofilm properties and enhanced antibiotic efficacy against S. aureus.
• Significant synergy was observed between IAFGP and daptomycin (an MRSA treatment) in vitro and in vivo.
• Synergy was also noted with ciprofloxacin and gentamicin, antibiotics not typically used for S. aureus infections.
• Combined treatment led to improved antibiotic permeation into bacterial cells.

Conclusions:

• IAFGP can enhance the efficacy of established antibiotics and potentiate those not commonly used against S. aureus.
• The combination of IAFGP with antibiotics presents a novel therapeutic strategy to combat MRSA and other resistant bacterial infections.
• IAFGP's ability to improve antibiotic permeation contributes to its synergistic effects, offering a promising approach to antimicrobial therapy.